一种含三氟甲氧基苯s-葡萄糖苷结构的化合物及其用途

Compound with trifluoromethoxybenzene-S-glucoside structure and application thereof

Abstract

The invention relates to the field of drugs related to diabetes, in particular to a sodium-glucose co-transporter-2 (SGLT2) inhibitor with the trifluoromethoxybenzene-S-glucoside structure, a preparation method of the inhibitor and the application of the inhibitor in preparation of drugs for diabetes. Please see the structural formula of the inhibitor in the specification.
本发明涉及与糖尿病相关的药物领域。具体而言,本发明涉及一种含三氟甲氧基苯S-葡萄糖苷结构的2型钠依赖性葡萄糖转运子(SGLT2)抑制剂、其制备方法以及在制备糖尿病药物中的应用。

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (6)

    Publication numberPublication dateAssigneeTitle
    CN-101445527-AJune 03, 2009天津药物研究院Five-membered heteroaromatics tolylene glucoside and preparation method and use thereof
    CN-104059042-ASeptember 24, 2014正大天晴药业集团股份有限公司C-triaryl glucoside SGLT-2 inhibitor
    CN-1190097-AAugust 12, 1998田边制药株式会社苯基乙基酮衍生物及其制备方法
    CN-1259119-AJuly 05, 2000诺沃挪第克公司Substituted 3,3-diamino-2-propenenitriles their preparation and use
    CN-1437608-AAugust 20, 2003布里斯托尔-迈尔斯斯奎布公司O-芳基葡糖苷sglt2抑制剂和方法
    WO-2010018435-A1February 18, 2010Hetero Research FoundationAmide glycosides

NO-Patent Citations (2)

    Title
    徐鸽,等: "2 型糖尿病治疗新靶点SGLT2 抑制剂的研究进展", 《现代生物医学进展》
    邵华,等: "含反式环己烷结构的C-葡萄糖苷类SGLT2 抑制剂的设计、合成与降血糖活性研究", 《有机化学》

Cited By (0)

    Publication numberPublication dateAssigneeTitle